CRNX
Price
$32.37
Change
-$0.00 (-0.00%)
Updated
Apr 24, 02:22 PM (EDT)
Capitalization
2.91B
14 days until earnings call
DYN
Price
$11.02
Change
+$0.24 (+2.23%)
Updated
Apr 24, 02:23 PM (EDT)
Capitalization
1.13B
7 days until earnings call
Ad is loading...

CRNX vs DYN

Header iconCRNX vs DYN Comparison
Open Charts CRNX vs DYNBanner chart's image
Crinetics Pharmaceuticals
Price$32.37
Change-$0.00 (-0.00%)
Volume$100
Capitalization2.91B
Dyne Therapeutics
Price$11.02
Change+$0.24 (+2.23%)
Volume$220
Capitalization1.13B
CRNX vs DYN Comparison Chart
Loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRNX vs. DYN commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Buy and DYN is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (CRNX: $32.38 vs. DYN: $10.78)
Brand notoriety: CRNX and DYN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 141% vs. DYN: 198%
Market capitalization -- CRNX: $2.91B vs. DYN: $1.13B
CRNX [@Biotechnology] is valued at $2.91B. DYN’s [@Biotechnology] market capitalization is $1.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileDYN’s FA Score has 1 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • DYN’s FA Score: 1 green, 4 red.
According to our system of comparison, DYN is a better buy in the long-term than CRNX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 5 TA indicator(s) are bullish while DYN’s TA Score has 4 bullish TA indicator(s).

  • CRNX’s TA Score: 5 bullish, 3 bearish.
  • DYN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CRNX is a better buy in the short-term than DYN.

Price Growth

CRNX (@Biotechnology) experienced а +9.47% price change this week, while DYN (@Biotechnology) price change was +37.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

CRNX is expected to report earnings on Aug 08, 2025.

DYN is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($2.91B) has a higher market cap than DYN($1.13B). CRNX YTD gains are higher at: -36.671 vs. DYN (-54.244). CRNX (-336.07M) and DYN (-342.21M) have comparable annual earnings (EBITDA) . CRNX has more cash in the bank: 1.35B vs. DYN (642M). DYN has less debt than CRNX: DYN (24M) vs CRNX (51.7M). CRNX has higher revenues than DYN: CRNX (1.04M) vs DYN (0).
CRNXDYNCRNX / DYN
Capitalization2.91B1.13B258%
EBITDA-336.07M-342.21M98%
Gain YTD-36.671-54.24468%
P/E RatioN/AN/A-
Revenue1.04M0-
Total Cash1.35B642M211%
Total Debt51.7M24M215%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
PROFIT vs RISK RATING
1..100
58
SMR RATING
1..100
76
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXDYN
RSI
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
80%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
87%
View a ticker or compare two or three
Ad is loading...
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DYN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSIAX39.26N/A
N/A
PGIM Quant Solutions Large-Cap Index A
FIFRX120.31N/A
N/A
Franklin Growth R6
MGLKX15.65N/A
N/A
MFS Global Real Estate R2
MLNCX20.80N/A
N/A
Morgan Stanley Instl Glbl Concntr C
WSACX24.79N/A
N/A
Wellington Shields All-Cap Instl

CRNX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with DNLI. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+3.55%
DNLI - CRNX
52%
Loosely correlated
+1.85%
XNCR - CRNX
52%
Loosely correlated
+2.07%
RVMD - CRNX
52%
Loosely correlated
+1.57%
TRDA - CRNX
52%
Loosely correlated
N/A
ETNB - CRNX
51%
Loosely correlated
+0.92%
More

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with CRNX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+8.78%
CRNX - DYN
50%
Loosely correlated
+3.55%
ROIV - DYN
48%
Loosely correlated
+2.98%
INZY - DYN
47%
Loosely correlated
-4.84%
RNA - DYN
47%
Loosely correlated
+4.18%
ERAS - DYN
47%
Loosely correlated
+2.90%
More